Acknowledgement to Referees.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 12, p. 1085, doi. 10.1007/s40261-018-0728-z
- Publication type:
- Article
Works matching IS 11732563 AND DT 2018 AND VI 38 AND IP 12
Results: 12
1
2
Response to “Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database”.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
3
Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
4
Safety, Tolerability, and Pharmacokinetics of the Novel Anti-influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 12, p. 1189, doi. 10.1007/s40261-018-0710-9
- By:
- Publication type:
- Article
5
Cardiovascular Toxicities with Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Patients: A Meta-Analysis of 77 Randomized Controlled Trials.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 12, p. 1109, doi. 10.1007/s40261-018-0709-2
- By:
- Publication type:
- Article
6
Signal Detection Between Fluoroquinolone Use and the Risk of Rhegmatogenous Retinal Detachment: Sequence Symmetry Analysis Using Nationwide South Korean Healthcare Database Between 2004 and 2015.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 12, p. 1179, doi. 10.1007/s40261-018-0708-3
- By:
- Publication type:
- Article
7
The Effects of Novel Antidiabetic Drugs on Albuminuria in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 12, p. 1089, doi. 10.1007/s40261-018-0707-4
- By:
- Publication type:
- Article
8
Economic Evaluations of Tyrosine Kinase Inhibitors for Patients with Chronic Myeloid Leukemia in Middle- and High-Income Countries: A Systematic Review.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 12, p. 1167, doi. 10.1007/s40261-018-0706-5
- By:
- Publication type:
- Article
9
Cost-utility of Sunitinib Versus Pazopanib in Metastatic Renal Cell Carcinoma in Canada using Real-world Evidence.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 12, p. 1155, doi. 10.1007/s40261-018-0705-6
- By:
- Publication type:
- Article
10
Bioequivalence and Pharmacokinetics of Bisoprolol-Amlodipine 5 mg/5 mg Combination Tablet versus Bisoprolol 5 mg Tablet and Amlodipine 5 mg Tablet: An Open-Label, Randomized, Two-Sequence Crossover Study in Healthy Chinese Subjects.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 12, p. 1145, doi. 10.1007/s40261-018-0700-y
- By:
- Publication type:
- Article
11
Multicenter, Open-Label Study of Long-Term Topiroxostat (FYX-051) Administration in Japanese Hyperuricemic Patients with or Without Gout.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 12, p. 1135, doi. 10.1007/s40261-018-0699-0
- By:
- Publication type:
- Article
12
Replacement Effects and Budget Impacts of Insurance Coverage for Sodium-Glucose Co-Transporter-2 Inhibitors on Oral Antidiabetic Drug Utilization.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 12, p. 1125, doi. 10.1007/s40261-018-0689-2
- By:
- Publication type:
- Article